Clinical Trial Update: Study of Drug Combination on Pharmacokinetics in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetics of a drug combination in healthy volunteers for hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C Infection | Phase 1 | Status: COMPLETED